INTECH Investment Management’s Damora Therapeutics DMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding DMRA
INTECH Investment Management's DMRA Position: Q3 2026 in Review
INTECH Investment Management sold out of Damora Therapeutics (DMRA) in Q3 2026, closing a stake of 9,505 shares — an estimated $247K sold.
INTECH Investment Management first reported a position in DMRA in Q2 2026 and held it in 1 quarter. The position peaked at $247K in Q2 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.
- INTECH Investment Management reported no remaining Damora Therapeutics position as of Q3 2026 after selling out during the quarter.
- INTECH Investment Management sold 9,505 Damora Therapeutics shares in Q3 2026, an estimated $247K.
- INTECH Investment Management first reported a position in Damora Therapeutics in Q2 2026 and held it in 1 quarter.
- INTECH Investment Management's Damora Therapeutics position peaked at $247K in Q2 2026.
- 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.
Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.